Pregabalin versus gabapentin in the management of peripheral neuropathic pain associated with post-herpetic neuralgia and diabetic neuropathy: a cost effectiveness analysis for the Greek healthcare setting. - Wikidata - wikimedia - TriplyDB

Pregabalin versus gabapentin in the management of peripheral neuropathic pain associated with post-herpetic neuralgia and diabetic neuropathy: a cost effectiveness analysis for the Greek healthcare setting.

Pregabalin versus gabapentin in the management of peripheral neuropathic pain associated with post-herpetic neuralgia and diabetic neuropathy: a cost effectiveness analysis for the Greek healthcare setting.

http://www.wikidata.org/entity/Q34753719

about

Cost of treatment of peripheral neuropathic pain with pregabalin or gabapentin in routine clinical practice: impact of their loss of exclusivity.A systematic review of cost-effectiveness modeling of pharmaceutical therapies in neuropathic pain: variation in practice, key challenges, and recommendations for the future.Neuropathic pain: a narrative review of etiology, assessment, diagnosis, and treatment for primary care providers.Can pregabalin prevent paclitaxel-associated neuropathy?--An ACCRU pilot trial.

P2860

Q33578200-20B85889-7034-457D-953E-830D867309F6 Q38827607-AE272F61-3E2D-4ADA-B32C-A11180F1B5A7 Q39250516-B4CBCD8F-92FA-4903-9818-0142A29B48A8 Q40757672-02442C11-42D4-40B0-B5B2-F99451FB46DF

P2860

Pregabalin versus gabapentin in the management of peripheral neuropathic pain associated with post-herpetic neuralgia and diabetic neuropathy: a cost effectiveness analysis for the Greek healthcare setting.

http://www.wikidata.org/entity/Q34753719

description

2013 nî lūn-bûn

@nan

2013 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Pregabalin versus gabapentin i ...... the Greek healthcare setting.

@ast

Pregabalin versus gabapentin i ...... the Greek healthcare setting.

@en

Pregabalin versus gabapentin i ...... the Greek healthcare setting.

@nl

type

label

Pregabalin versus gabapentin i ...... the Greek healthcare setting.

@ast

Pregabalin versus gabapentin i ...... the Greek healthcare setting.

@en

Pregabalin versus gabapentin i ...... the Greek healthcare setting.

@nl

prefLabel

Pregabalin versus gabapentin i ...... the Greek healthcare setting.

@ast

Pregabalin versus gabapentin i ...... the Greek healthcare setting.

@en

Pregabalin versus gabapentin i ...... the Greek healthcare setting.

@nl

P1433

Q34753719-13AFFFA3-AADE-4535-8D91-0524D9253921

P1476

Q34753719-FC612120-5C8F-46DC-9E47-CA2CA92CC273

P2093

Q34753719-44693895-9F5B-45BD-AB46-5D30E82E3655

Q34753719-AD3E57C7-97C8-4B67-A310-4C149B4995BE

Q34753719-BB9B6EC4-4832-465E-A704-81783BE26EDF

Q34753719-E4DF1694-05AC-4383-97E2-9FC65480C46F

Q34753719-EAF2306A-1E84-441B-B5BB-1F868CABF873

P2860

Q34753719-12B67AB8-37EA-4386-B82C-2BA8DA529C41

Q34753719-179D537E-76D3-43EB-990A-B2184D5FF542

Q34753719-29119B15-0C2E-467B-B2B7-CD1CFA58A74F

Q34753719-37F169DB-E093-4BD5-B589-630A5EBD03ED

Q34753719-3AF04BC2-F7C2-4C94-900B-99D9EB9701F6

Q34753719-4FF177DF-1FBF-4D1F-97BF-81087584D4BC

Q34753719-5756869A-F9E6-43AE-84EF-9791B6CF6B29

Q34753719-7BB1057D-3974-4F52-8283-67A59BFA1CBC

Q34753719-8A50443E-89ED-4358-BF72-65355CA65B79

Q34753719-8F63D72E-9291-4252-A8D0-6C20A4AB6041

P2888

Q34753719-26BEE301-C6C4-41B8-8337-CB95D000B00A

P304

Q34753719-7A06B64D-C285-414B-8157-B2D576E0AB0D

P31

Q34753719-A83DDB22-A603-4E42-9ED9-C8EEB68EED3F

P356

Q34753719-935643E1-0B84-41E6-8807-C4DE15D8E1FA

P478

Q34753719-B2759F23-40D4-4431-9F1E-C01F4C1C7D81

P50

Q34753719-5AB10E3F-069A-4CCD-88C7-027883B8458D

P577

Q34753719-01305F9B-7BF2-40C6-854F-1ACB0806C954

P5875

Q34753719-6231E736-8E88-4E6C-8E35-963479344C17

P6179

Q34753719-4668121C-6EF4-4977-B9D8-E157B9E047EC

P698

Q34753719-2D3F9FA6-6FF0-4667-B832-E48DD97C1C80

P921

Q34753719-43D285AE-71AC-4F7F-B195-AD1DC62936DA

Q34753719-7042A143-4430-403C-ABE6-67039A4B7663

Q34753719-f4e5f950-4cf7-4511-9eec-2df3e221c5b7

P932

Q34753719-69B21BD7-A569-4A3D-ACAF-17C2477E2925

P356

1471-2377-13-56

P1433

P1476

Pregabalin versus gabapentin i ...... r the Greek healthcare setting

@en

P2093

Elli Vitsou

http://www.w3.org/2001/XMLSchema#string

Ioannis Petrakis

http://www.w3.org/2001/XMLSchema#string

John Kyriopoulos

http://www.w3.org/2001/XMLSchema#string

Kostas Athanasakis

http://www.w3.org/2001/XMLSchema#string

Leonidas Lyras

http://www.w3.org/2001/XMLSchema#string

P2860

Gabapentin for the Treatment of Postherpetic Neuralgia: A Randomized Controlled Trial

Practice parameter: treatment of postherpetic neuralgia: an evidence-based report of the Quality Standards Subcommittee of the American Academy of Neurology.

A cost-consequences analysis of the effect of pregabalin in the treatment of peripheral neuropathic pain in routine medical practice in primary care settings.

How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations.

Use of cost-effectiveness analysis in health-care resource allocation decision-making: how are cost-effectiveness thresholds expected to emerge?

Neuropathic pain: quality-of-life impact, costs and cost effectiveness of therapy.

Clinical characteristics and economic costs of patients with painful neuropathic disorders.

Substitution of gabapentin therapy with pregabalin therapy in neuropathic pain due to peripheral neuropathy.

Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomised, double-blind, multicentre, placebo-controlled trial of flexible- and fixed-dose regimens.

Postherpetic neuralgia--pathogenesis, treatment, and prevention.

P2888

1471-2377-13-56

P304

56

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2377-13-56

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P50

Eleftheria Karampli

P577

2013-06-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

237015856

http://www.w3.org/2001/XMLSchema#string

P6179

1026875137

http://www.w3.org/2001/XMLSchema#string

P698

23731598

http://www.w3.org/2001/XMLSchema#string

P921

neuropathic pain

pain management

P932

3674934

http://www.w3.org/2001/XMLSchema#string